Zenyaku Kogyo to Initiate Preclinical Study for Nucleic Acid Medicine for Psoriasis as Early as Next Year

Zenyaku Kogyo aims to start a preclinical study of its investigational nucleic acid medicine for the treatment of psoriasis/rheumatoid arthritis as early as next year, it said in a recent interview with Jiho. The agent is a nucleic acid medicine...read more